2020
DOI: 10.1016/j.steroids.2020.108586
|View full text |Cite
|
Sign up to set email alerts
|

Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
23
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(29 citation statements)
references
References 42 publications
3
23
0
1
Order By: Relevance
“…Vitamin D may have a possible beneficial influence on this signal transduction pathway and its effects, however few studies investigate the link between them. In an Alzheimer’s disease rat model, vitamin D analogue treatment significantly increased the Nrf2 expression and significantly decreased a lipid peroxidation marker, the malondialdehyde (MDA) levels compared to non-treated group [ 35 ]. There is one study that hypothesizes that lithocholic acid can bind to VDR, and VDR activates SIRT1/Nrf2 signal pathway and results in beneficial effects of lithocholic acid on injured intestinal barrier function [ 36 ].…”
Section: Discussion Limitations and Strengthsmentioning
confidence: 99%
“…Vitamin D may have a possible beneficial influence on this signal transduction pathway and its effects, however few studies investigate the link between them. In an Alzheimer’s disease rat model, vitamin D analogue treatment significantly increased the Nrf2 expression and significantly decreased a lipid peroxidation marker, the malondialdehyde (MDA) levels compared to non-treated group [ 35 ]. There is one study that hypothesizes that lithocholic acid can bind to VDR, and VDR activates SIRT1/Nrf2 signal pathway and results in beneficial effects of lithocholic acid on injured intestinal barrier function [ 36 ].…”
Section: Discussion Limitations and Strengthsmentioning
confidence: 99%
“…El-Din et al demonstrated that Nrf2 and its downstream anti-oxidant effectors were decreased in AD rats, while the neuro-inflammation as evidenced by TNF-α and phosphorylated ERK1/2 that led to the hyperphosphorylation of tau protein were increased (Fig. 2) [71]. Maxacalcitol, a vitamin D analogue, significantly improved cognitive impairment of AD rats via elevating Nrf2 signaling pathway as well as reducing the hyperphosphorylation of ERK1/2 and tau proteins [71], making AD more curable than inevitable (Fig.…”
Section: Vitamin Metabolismmentioning
confidence: 96%
“…2) [71]. Maxacalcitol, a vitamin D analogue, significantly improved cognitive impairment of AD rats via elevating Nrf2 signaling pathway as well as reducing the hyperphosphorylation of ERK1/2 and tau proteins [71], making AD more curable than inevitable (Fig. 2).…”
Section: Vitamin Metabolismmentioning
confidence: 98%
“…It has been reported that VitD inhibits MAPK signalling pathway activation [16]. The MAPK signalling pathway participates in the physiological functions of various cancer cells in vivo, including proliferation, apoptosis and differentiation [17].…”
Section: Vitd Inhibited the Mapk Signalling Pathway Of Oscc By Inhibimentioning
confidence: 99%